We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.
BCC is the most common type of skin cancer. It starts in the top layer of the skin, and if it's found early, most BCC can be surgically removed.
Sometimes, BCC becomes more serious and can be called advanced BCC. When BCC is advanced, it's either locally advanced or metastatic.
If you have advanced BCC and surgery or radiation aren't treatment options, then you and your doctor may decide that Erivedge is the right treatment for you.
Before starting treatment, it's important to understand how Erivedge may work inside the body.
Exposure to Erivedge during pregnancy: If you become pregnant during treatment with Erivedge, you or your healthcare provider should report your pregnancy to Genentech at (888) 835-2555.
Erivedge may cause your advanced BCC to shrink, or it may help control your disease.
In a clinical study, 104 adults took Erivedge for their advanced BCC. Of the 104 patients, 96 were evaluated for overall response rate (63 had locally advanced BCC and 33 had metastatic BCC).
Half of the patients who responded to Erivedge saw improvement for less than 7.6 months, and half saw improvement for more than 7.6 months.
Your healthcare provider may permanently stop Erivedge if you develop a severe skin reaction.
Erivedge can cause absence of menstrual periods (amenorrhea) in females who are able to become pregnant. It is not known if amenorrhea is permanent. Talk to your healthcare provider if you have concerns about fertility.
These are not all of the possible side effects of Erivedge. Because everyone is different, it is not possible to predict what side effects any one person will have or how severe they may be. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.